| |
| |
|
| Insider
Information: |
Blight Andrew |
| Relationship: |
Chief Scientific Officer |
| City: |
Hawthorne |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
76,558 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$38,432 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
76,558 |
|
|
| Total
Value |
$38,432 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Chief Scientific Officer |
2017-02-09 |
76,558 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-02-15 |
4 |
AS |
$23.23 |
$104,861 |
D/D |
(4,487) |
23,301 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-02-15 |
4 |
OE |
$2.60 |
$11,666 |
D/D |
4,487 |
27,788 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,600 |
36,901 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-03-10 |
4 |
AS |
$17.45 |
$71,699 |
D/D |
(4,000) |
32,901 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-04-07 |
4 |
AS |
$18.29 |
$65,830 |
D/D |
(3,586) |
29,315 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-05 |
4 |
AS |
$29.84 |
$112,327 |
D/D |
(3,700) |
29,315 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-05 |
4 |
AS |
$31.17 |
$127,270 |
D/D |
(4,000) |
33,015 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-05 |
4 |
AS |
$32.38 |
$172,543 |
D/D |
(5,300) |
44,015 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-05 |
4 |
OE |
$2.60 |
$52,000 |
D/D |
20,000 |
49,315 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-05 |
4 |
AS |
$32.04 |
$225,761 |
D/D |
(7,000) |
37,015 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-11 |
4 |
S |
$31.50 |
$25,220 |
D/D |
(800) |
29,315 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-11 |
4 |
OE |
$2.60 |
$2,080 |
D/D |
800 |
30,115 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-12 |
4 |
OE |
$2.60 |
$75,920 |
D/D |
29,200 |
58,515 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-12 |
4 |
S |
$30.82 |
$275,218 |
D/D |
(8,900) |
39,915 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-12 |
4 |
S |
$31.26 |
$277,239 |
D/D |
(8,800) |
31,115 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-12 |
4 |
S |
$31.70 |
$57,087 |
D/D |
(1,800) |
29,315 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2008-06-12 |
4 |
S |
$30.52 |
$282,037 |
D/D |
(9,200) |
49,315 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2009-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
45,315 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2009-12-01 |
4 |
AS |
$24.51 |
$110,275 |
D/D |
(4,500) |
40,815 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2010-02-02 |
4 |
AS |
$30.00 |
$136,020 |
D/D |
(4,534) |
36,281 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2010-03-02 |
4 |
AS |
$32.21 |
$134,407 |
D/D |
(4,173) |
32,108 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
52,108 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2010-12-01 |
4 |
D |
$26.47 |
$142,488 |
D/D |
(5,383) |
46,725 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2011-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
61,725 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2011-12-01 |
4 |
AS |
$22.92 |
$160,440 |
D/D |
(7,000) |
54,725 |
0 |
- |
|
72 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
